Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Glucagon Market

Glucagon Market Share

Report ID: GMI9179
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Glucagon Market Share

The glucagon industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Glucagon Market Companies

Some of the eminent market participants operating in the glucagon industry include:

Amgen Inc.
Avalon Pharma Private Limited
Bachem Holding AG
Eli Lilly and Company
Fresenius SE & Co. KGaA
Fujifilm Holdings Corporation
Novo Nordisk A/S
Pfizer, Inc.
Svar Life Science
Taj Pharmaceuticals Ltd.
Xeris Biopharma Holdings, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Glucagon market size was USD 422.6 million in 2023 and is expected to register 5.9% CAGR from 2024-2032 owing to the increasing prevalence of diabetes and increasing research & development activities worldwide.

Glucagon industry from the injectable segment is expected to reach USD 364.7 million by 2032 due to a rapid onset of action, typically within minutes of administration and therefore being crucial for emergency situations.

North America glucagon industry is expected to register 5.7% CAGR from 2024-2032 due to highly developed pharmaceutical industry with advanced manufacturing capabilities in the region.

Amgen Inc., Bachem Holding AG, Eli Lilly and Company, Fresenius SE & Co. KGaA, Fujifilm Holdings Corporation, Novo Nordisk A/S, Pfizer, Inc., Svar Life Science, Taj Pharmaceuticals Ltd., and Xeris Biopharma Holdings, Inc., are some of the major glucagon companies worldwide.